Trial Outcomes & Findings for The Effect of Fruit/Vegetable Drinks on the Human Intestine (NCT NCT02377063)
NCT ID: NCT02377063
Last Updated: 2019-09-09
Results Overview
Changes in microbial count (%) were calculated as the values at day 4 minus the values at baseline
COMPLETED
NA
25 participants
baseline and day 4
2019-09-09
Participant Flow
UCLA IRB-approved flyers were posted around campus. Interested subjects who respond to the approved flyers called the research site and a coordinator conducted a screening by utilizing the screening script. Eligible subjects will be scheduled for a screening visit began 5/12/2015- 7/7/2015.
Participant milestones
| Measure |
Pressed Juice
Subjects will consume pressed juice supplementation for 3 days
Pressed Juice: Subjects will be taking vegetable/fruit juice supplementation for 3 days. Blood, urine and stool samples will be collected at baseline, day 4 and day 17.
|
|---|---|
|
Overall Study
STARTED
|
25
|
|
Overall Study
COMPLETED
|
20
|
|
Overall Study
NOT COMPLETED
|
5
|
Reasons for withdrawal
| Measure |
Pressed Juice
Subjects will consume pressed juice supplementation for 3 days
Pressed Juice: Subjects will be taking vegetable/fruit juice supplementation for 3 days. Blood, urine and stool samples will be collected at baseline, day 4 and day 17.
|
|---|---|
|
Overall Study
Non-compliance
|
5
|
Baseline Characteristics
Five subjects who did not provide fecal samples were excluded from the analysis.
Baseline characteristics by cohort
| Measure |
Pressed Juice
n=25 Participants
Subjects will consume pressed juice supplementation for 3 days
Pressed Juice: Subjects will be taking vegetable/fruit juice supplementation for 3 days. Blood, urine and stool samples will be collected at baseline, day 4 and day 17.
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants • Five subjects who did not provide fecal samples were excluded from the analysis.
|
|
Age, Categorical
Between 18 and 65 years
|
25 Participants
n=5 Participants • Five subjects who did not provide fecal samples were excluded from the analysis.
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants • Five subjects who did not provide fecal samples were excluded from the analysis.
|
|
Sex: Female, Male
Female
|
19 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
11 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
10 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: baseline and day 4Population: All participants for whom colonic flora composition were measured at baseline and day 4.
Changes in microbial count (%) were calculated as the values at day 4 minus the values at baseline
Outcome measures
| Measure |
Mixed Fruit and Vegetable Juice 6 Bottles
n=20 Participants
All participants consumed 6 bottles of mixed fruit and vegetable juice daily for 3 days.
|
|---|---|
|
Change in Colonic Flora Composition
Phylum Firmicutes at day 0
|
52.4 percentage of total bacteria
Standard Error 3.9
|
|
Change in Colonic Flora Composition
Phylum Firmicutes at day 4
|
41.2 percentage of total bacteria
Standard Error 3.5
|
|
Change in Colonic Flora Composition
Phylum Bacteroidetes at day 0
|
41.4 percentage of total bacteria
Standard Error 3.8
|
|
Change in Colonic Flora Composition
Phylum Bacteroidetes at day 4
|
51.9 percentage of total bacteria
Standard Error 3.5
|
Adverse Events
Pressed Juice
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Zhaoping Li, MD, PhD - Principal Investigator
UCLA Center for Human Nutrition
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place